Literature DB >> 19649921

Bacteriophage therapy for the treatment of infections.

Andrzej Górski1, Ryszard Miedzybrodzki, Jan Borysowski, Beata Weber-Dabrowska, Małgorzata Lobocka, Wojciech Fortuna, Sławomir Letkiewicz, Michał Zimecki, Grace Filby.   

Abstract

Increasing levels of antibiotic resistance constitutes one of the main challenges in medicine today, and has increased interest in the potential use of alternative antibacterial agents. One of the most interesting 'classes' of novel antibacterials used to combat multidrug-resistant bacteria is bacteriophages, which are viruses that specifically infect and kill bacterial cells. This review discusses the current status of bacteriophage therapy, including the experience of one expert center specializing in this form of treatment.

Entities:  

Mesh：

Year:  2009        PMID： 19649921

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN： 1472-4472


  48 in total

1.  P-27/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections.

Authors:  Ragini Gupta; Yogendra Prasad
Journal:  Curr Microbiol       Date:  2011-04-27       Impact factor: 2.188

2.  Impact of relative humidity and collection media on mycobacteriophage D29 aerosol.

Authors:  Keyang Liu; Zhanbo Wen; Na Li; Wenhui Yang; Jie Wang; Lingfei Hu; Xiaokai Dong; Jianchun Lu; Jinsong Li
Journal:  Appl Environ Microbiol       Date:  2011-12-22       Impact factor: 4.792

3.  The phage therapy paradigm: prêt-à-porter or sur-mesure?

Authors:  Jean-Paul Pirnay; Daniel De Vos; Gilbert Verbeken; Maia Merabishvili; Nina Chanishvili; Mario Vaneechoutte; Martin Zizi; Geert Laire; Rob Lavigne; Isabelle Huys; Guy Van den Mooter; Angus Buckling; Laurent Debarbieux; Flavie Pouillot; Joana Azeredo; Elisabeth Kutter; Alain Dublanchet; Andrzej Górski; Revaz Adamia
Journal:  Pharm Res       Date:  2010-11-10       Impact factor: 4.200

4.  Prevalence of Staphylococcus aureus and lack of its lytic bacteriophages in the anterior nares of patients and healthcare workers at a rural clinic.

Authors:  Vijay H Aswani; Sanjay K Shukla
Journal:  Clin Med Res       Date:  2010-10-25

5.  Prophylactic effect of bacteriophages on mice subjected to chemotherapy-induced immunosuppression and bone marrow transplant upon infection with Staphylococcus aureus.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocieba; Beata Weber-Dabrowska; Jan Borysowski; Andrzej Górski
Journal:  Med Microbiol Immunol       Date:  2009-12-02       Impact factor: 3.402

6.  Selection of phages and conditions for the safe phage therapy against Pseudomonas aeruginosa infections.

Authors:  Victor Krylov; Olga Shaburova; Elena Pleteneva; Sergey Krylov; Alla Kaplan; Maria Burkaltseva; Olga Polygach; Elena Chesnokova
Journal:  Virol Sin       Date:  2015-02-05       Impact factor: 4.327

7.  Biosafety evaluation of bacteriophages for treatment of diarrhea due to intestinal pathogen Escherichia coli 3-2 infection of chickens.

Authors:  Hao Li; Man-Li Ma; Hui-Jun Xie; Jian Kong
Journal:  World J Microbiol Biotechnol       Date:  2011-05-15       Impact factor: 3.312

8.  Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii.

Authors:  Hongjiang Yang; Li Liang; Shuxiang Lin; Shiru Jia
Journal:  BMC Microbiol       Date:  2010-04-29       Impact factor: 3.605

9.  Eradication of Enterococcus faecalis by phage therapy in chronic bacterial prostatitis--case report.

Authors:  S Letkiewicz; R Miedzybrodzki; W Fortuna; B Weber-Dabrowska; A Górski
Journal:  Folia Microbiol (Praha)       Date:  2009-11-24       Impact factor: 2.099

10.  Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.

Authors:  Michał Zimecki; Jolanta Artym; Maja Kocieba; Beata Weber-Dabrowska; Jan Borysowski; Andrzej Górski
Journal:  BMC Microbiol       Date:  2009-08-17       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.